Your Notifications
All done, no notifications

About Dr. Professor Liu Ying

  • Professor Liu Ying is a senior specialist in pediatric haematology and pediatric oncology, with a focused expertise in pediatric lymphoma and leukaemia.
  • She has over 30 years of clinical experience in diagnosing and treating complex pediatric hematologic and oncologic disorders.
  • She is currently affiliated with the Pediatric Haematology and Oncology Department at Beijing GoBroad Boren Hospital, where she contributes extensive expertise in advanced pediatric cancer care.
  • Professor Liu is widely respected for her work in chemotherapy, immunotherapy, and the management of critical care for children with haematological malignancies.

Conditions treated byProfessor Liu Ying

  • Pediatric leukemia
  • Pediatric lymphoma
  • Refractory and relapsed B-cell lymphoma in children and adolescents
  • Pediatric hematologic malignancies
  • Critical haematological and oncological conditions in children

Area of Interest

  • Pediatric leukemia and lymphoma management
  • Chemotherapy for pediatric haematological diseases
  • Immunotherapy, including CAR-T cell therapy
  • Management of critically ill pediatric haematology-oncology patients
  • Clinical research in pediatric hematologic oncology

Work Experiences

  • Professor Liu Ying served at the Pediatric Haematology and Oncology Department, PLA General Hospital from 1995 to 2019
  • Global Team of Board Certified Surgeons and Medical Specialists
  • Written Second Opinion report delivered within 5 days
  • Option to avail the Video Consultation with the Lead Doctor of the board

Access Our most trusted Medical Second Opinion

Required | alphabets and spaces
Required | A valid, working email address
Required | A valid contact

Telemedicine Doctors

Do you know?

You can book a video consultation with Dr. Professor Liu Ying on our platform

RESEARCH PAPERS AND PUBLICATIONS (2)

  • Professor Liu Ying published more than 20 papers as the first author in core medical journals
  • She also published 3 papers in SCI-indexed journals

Share Your Experience about Dr. Professor Liu Ying

PROCEDURES

  • CAR-T

FREQUENTLY ASKED QUESTIONS

Is Professor Liu Ying doing teleconsultation on the MediGence platform?
Professor Liu Ying is available to teleconsult on the MediGence platform.
How long is the consultation?
The consultation can last from 15 to 30 minutes. It may exceed the estimated time, depending on the patient’s queries and the doctor's medical suggestions.
How soon can the consultation be organised?
We have Medical specialists and board-certified doctors on our panel of doctors. The consultation will be organised within 24 to 48 hours or based on the availability of the doctor and the patient.
Is a follow-up consultation included in the consultation price?
No, the follow-up consultation fee is not included in the consultation price. The patient will be required to re-book the consultation.
How do I share my medical record with the doctor for review?
The option to share your medical records is available between the steps of the form provided to you on the website.
Can I book my procedure with the doctor post-consultation?
Yes. If you are satisfied with the consultation, you can go ahead with treatment packages for your diagnosis with the help of our case managers.
Can you get an estimate for the procedure?
Yes. The cost estimate will be provided to you by our case manager, including the doctor’s opinion, the cost estimate, and crucial information about travelling to your medical destination.

FAQ's Related to Hemato Oncologist

What is Pediatric Hemato-Oncology?
Pediatric Hemato-Oncology is a medical speciality that focuses on diagnosing and treating blood disorders (haematology) and cancers (oncology) in children, adolescents, and young adults. This includes leukaemia, lymphoma, solid tumours, and blood diseases like anaemia or clotting disorders.
What are the treatment options for pediatric cancers?
Treatment varies based on the type and stage of cancer, and may include:
What is CAR T-cell therapy?
CAR T-cell therapy is an advanced immunotherapy that involves modifying a patient’s T-cells to recognise and attack cancer cells, especially effective in certain types of relapsed or resistant leukaemia and lymphoma.
Is childhood cancer curable?
Yes, many childhood cancers have high cure rates, especially when diagnosed early and treated at specialised centres. Advances in research and personalised medicine have significantly improved survival rates.

Reviewer

Dr. Vijita Jayan
Dr. Vijita Jayan

BPT, MPT (Neuro)

18 Years of Experience

With over 18 years of distinguished clinical experience, Dr. Vijita Jayan is a highly accomplished Clinical Director and Rehabilitation Specialist, renowned for her expertise in neuro-rehabilitation, functional recovery, and mobility-dependent case management. Her extensive practical knowledge enables her to design and implement individualized, evidence-based rehabilitation protocols that consistently yield measurable patient outcomes. A prolific researcher and academic writer, she has authored numerous peer-reviewed articles and research papers, significantly advancing the field of rehabilitative medicine. The recipient of multiple prestigious accolades, Dr. Jayan is widely regarded as one of the foremost authorities in Physical Medicine and Rehabilitation, continually shaping neuro-rehabilitative care through research, innovation, and clinical excellence. View More

Last Reviewed - January 2026

Author

Dr. Shagufta Parveen
Dr. Shagufta Parveen

Doctor of Pharmacy

3 Years of Experience

Dr. Shagufta Parveen is a Clinical researcher and medical writer with expertise in clinical pharmacology and pharmacotherapeutics. She holds a B.Pharm and Doctor of Pharmacy (Post-Baccalaureate) degree from Teerthanker Mahaveer University, Moradabad.

During her clinical stint at BLK-Max Super Speciality Hospital and Indraprastha Apollo Hospital, she gained hands-on experience in the Clinical Pharmacology Department. Combining scientific knowledge with strong medical writing skills, Dr. Shagufta develops evidence-based healthcare content, treatment guides, and patient education resources.

Her work focuses on simplifying complex medical concepts while maintaining scientific accuracy, helping readers better understand healthcare advancements and treatment options.

In addition to her writing expertise, she is actively involved in scientific research and has contributed to peer-reviewed publications.

Her research work is accessible through the following links:

https://scholar.google.com/citations?user=lMVK1eIAAAAJ&hl=en

https://carcinogenesis.com/index.php/JOC/article/view/870

https://carcinogenesis.com/index.php/JOC/article/view/868

https://wjpsronline.com/abstract/0000000760

. View More